Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Alpha IVF Founder Signals Strong Confidence as "Intention to Deal" Suggests Significant Undervaluation?
In a move that serves as a massive vote of confidence for shareholders, Dato’ Dr. Lee Soon Soo, the Managing Director of Alpha IVF Group Berhad, has officially signalled his intention to trade company securities during the current Closed Period (the restricted window preceding financial results).
While "Dealing During a Closed Period" is a regulatory requirement under Chapter 14 of the Listing Requirements, it is rarely utilized unless an insider sees a critical opportunity to accumulate shares.
Why This Is a Major Bullish Signal:
- Buying the Discount: Dato' Dr. Lee already controls a dominant 44.45% stake (2.16 billion shares) in the company. When a founder who already holds nearly half the company signals an intent to deal even more, it is a classic indicator that the person believes the market is currently mispricing the stock.
- The "Closed Period" Urgency: Most directors wait for the open period to avoid the transparency of a public declaration. By announcing his intent to deal now; just as the company prepares its latest financial data, it suggests he views the current share price as too attractive to ignore, even for a few weeks.
- Skin in the Game: The filing reveals a deeply entrenched commitment, with interests spread across his direct holdings, his investment vehicle (ACE Specialists Sdn Bhd), and his immediate family. This isn't just a corporate move; it’s a personal bet on the company’s growth trajectory.
- Market Transparency: By complying with the Companies Act 2016 and providing a granular breakdown of his holdings, the MD is signalling total transparency, which historically bolsters investor confidence and reinforces the "Strong Buy" sentiment from the top.
When the man who built, the company is looking to increase his exposure while the rest of the market is waiting for news, it is a loud and clear message: Alpha IVF is currently undervalued.
